Overexpression of adhesion molecules and barrier molecules is associated with differential infiltration of immune cells in non-small cell lung cancer
Young Kwang Chae(Northwestern University), Francis J. Giles(Northwestern University), Sarita Agte(Northwestern University), Wooyoung M. Choi(Northwestern University), Marcelo Cruz(Centro Científico Tecnológico - Nordeste), Wade T. Iams(Vanderbilt University Medical Center), William Han Bae(Northwestern University), Maria Matsangou(Northwestern University), Jonathan F. Anker(Tisch Hospital), Andrew A. Davis(Northwestern University)
Cited by 43
Related Papers
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials
|The Lancet Oncology|2019|537
Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC)
|Journal for ImmunoTherapy of Cancer|2018|468
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|459
Immunotherapeutic approaches for small-cell lung cancer
|Nature Reviews Clinical Oncology|2020|346